Stay updated on Daratumumab with Bortezomib/Dexamethasone Clinical Trial
Sign up to get notified when there's something new on the Daratumumab with Bortezomib/Dexamethasone Clinical Trial page.

Latest updates to the Daratumumab with Bortezomib/Dexamethasone Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPublications section now includes a PubMed entry for the trial (AMN006) with a note that publications are automatically filled from PubMed. The HHS Vulnerability Disclosure section was removed and the revision label updated from v3.3.2 to v3.3.3; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2 on the study page; no substantive content changes to study details or eligibility criteria were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1. No visible changes to study details, eligibility criteria, or trial outcomes.SummaryDifference0.1%

- Check48 days agoChange DetectedFunding/operating status banner removed. Core trial details and links remain unchanged.SummaryDifference0.4%

- Check62 days agoChange DetectedNo significant additions or deletions were detected on the Study Details page for NCT03695744; the content and layout appear unchanged from the prior version.SummaryDifference0.5%

- Check91 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference3%

Stay in the know with updates to Daratumumab with Bortezomib/Dexamethasone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab with Bortezomib/Dexamethasone Clinical Trial page.